Tolvaptan add‐on therapy in patients with acute heart failure: A systematic review and meta‐analysis
Abstract This study aimed to investigate the short‐term efficacy and safety of tolvaptan as an add‐on to traditional diuretics in patients with acute heart failure (AHF). The PubMed, EMBASE, Cochrane Library, and Web of Science databases were comprehensively searched for all randomized controlled tr...
Saved in:
Main Authors: | Xiandu Luo (Author), Qi Jin (Author), Yanqing Wu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tolvaptan response predictors in acute heart failure patients with congestion
by: Hindun Wilda Risni, et al.
Published: (2022) -
Total body fluid is the factor that affects the pharmacokinetics of tolvaptan, and its efficacy, in acute worsening heart failure patients
by: Takahiro Kato, et al.
Published: (2023) -
Efficacy and safety of Shenfu injection for the treatment of post-acute myocardial infarction heart failure: A systematic review and meta-analysis
by: Yanhua Wu, et al.
Published: (2022) -
Efficacy of pharmacologic therapies in patients with acute heart failure: A network meta-analysis
by: Hengheng Dai, et al.
Published: (2022) -
Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
by: Xu-Qin Du, et al.
Published: (2021)